InvestorsHub Logo

CATTDOGG12347

01/27/18 1:04 PM

#51340 RE: Donjayouworry #51338

We’re a lot further along in trials and partnerships then ever before Donna. Different animal at this point with the company being on the verge of income. AXAL should be a shoe in for the EU with re to efficacy and pricing.

oakrock

01/27/18 4:45 PM

#51360 RE: Donjayouworry #51338

Poison Pill. Shares can be protection from hostile takeover, insurance of many kinds, optional, but prudent to have the tool. Fundamental, but a big negative perception. I pray never used and we can go the distance with our 70 mill, plus future cash flow. btw....The BOD who left seemed to not do much for us in the past. Tom Ridge big name, seemed to do zippo for us, for example.

tx_farmer

01/27/18 8:24 PM

#51377 RE: Donjayouworry #51338

I think its because shareholders expect this:

https://www.fiercebiotech.com/partnering/novartis-tackles-immuno-oncology-a-750m-aduro-deal-for-new-r-d-group

Instead we get another BS authorized share increase. BOD have to go